2014 Analysis of the German Hospital Tumor Marker Testing Market

◆発行会社(リサーチ会社):Venture Planning Group
Local LicenseUSD3,850 ⇒換算¥415,800見積依頼/購入/質問フォーム
Global LicenseUSD8,500 ⇒換算¥918,000見積依頼/購入/質問フォーム
DataPackUSD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
※弊社H&Iグローバルリサーチ株式会社はVenture Planning Group社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Venture Planning Group社の概要はこちらでご確認いただけます。


This new report from Venture Planning Group contains 530 pages, 40 tables, and presents a comprehensive analysis of the German hospital tumor marker testing market, including:  

  • Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. 
  • Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. 
  • Test volume and sales forecasts for 40 tumor markers performed in German hospitals. 
  • Current instrumentation technologies and feature comparison of leading analyzers. 
  • Sales and market shares of leading suppliers. 
  • Emerging diagnostic technologies and their potential market applications. 
  • Product development opportunities. 
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. 
  • Business opportunities and strategic recommendations for suppliers. 

             Contains 530 pages and 40 tables





★医療情報レポート[2014 Analysis of the German Hospital Tumor Marker Testing Market]についてメールでお問い合わせはこちら